ライフサイエンスコーパス: flare

1 by episodes of quiescence and exacerbation (flares).

2 to suppress disease and were followed until flare.

3 s 1 to 2 weeks before a rheumatoid arthritis flare.

4 bled estimation of flared gas volume at each flare.

5 of 0.73 (0.6-0.84; p=0.0013) for predicting flare.

6 linicodemographic parameter predicted future flare.

7 ts with reactivation, 10 (43%) had hepatitis flare.

8 well tolerated, with a low incidence of IgM flare.

9 asurements of inflammatory cells and aqueous flare.

10 gnetic flux rope during a classic two-ribbon flare.

11 ients (both in treatment group B) had an IgM flare.

12 feedback cycle between them that leads to AD flare.

13 surgery, and anterior chamber (AC) cells and flare.

14 ents who developed a severe aminotransferase flare.

15 arly from the study were counted as having a flare.

16 ign of the calcium and light dual integrator FLARE.

17 , and tetracycline) and the occurrence of RA flares.

18 se toward remission, while preventing future flares.

19 on of the gut microbiota during inflammatory flares.

20 ncluding earthquakes, forest fires and solar flares.

21 of the mTOR pathway associated with symptom flares.

22 y transient localized Rho activation, or Rho flares.

23 ons on rheumatoid arthritis pathogenesis and flares.

24 ) cells was predictive of the development of flares.

25 of anti-IL-1beta biological therapy for gout flares.

26 above newly emerging ARs, days before first flares.

27 ient enrollment and not during acute symptom flares.

28 at least outside of periods of acute symptom flares.

29 iginating from the radiation belts and solar flares.

30 me-specific BC yields for a diverse range of flares.

31 gas discharge sites were imaged as acoustic flares.

32 aphylococcus aureus loads, especially during flares.

33 thematosus (SLE) patients undergoing disease flares.

34 us erythematosus with plasmablast-associated flares.

35 ng organ damage and life-threatening disease flares.

36 ion medications, and numbers of and times to flares.

37 the region, 5 accounted for 71% of the total flaring.

38 onths, and use of accessory muscles or nasal flaring.

39 ) was higher than that for those who did not flare (1.186 mg/kg/week) but was not statistically signi

40 association with a soft gamma-ray/hard-X-ray flare(18-21).

41 of the IMP for active JIA-U (median time to flare 188 days [range 42-413 days).

42 pulses powered by magnetar bursts and giant flares(3,4,12,13).

43 Increase in aqueous flare 6.3 +/- 16.4 photon units (pu)/ms vs 3.7 +/- 8.9 p

44 t to earlier studies, contributions from gas flaring (6%), power plants (9%), and open fires (12%) ar

45 Despite HBV flare, 67 (34.9%) patients had a favorable outcome of HB

46 a musical instrument where a player's voice flares a membrane's vibration through oscillating air pr

47 ane are close to expected values for typical flares according to the US EPA (98%).

48 5 (N = 23,487) and satellite observations of flaring activity during pregnancy within 5 km of materna

49 V404 Cygni during a recent period of strong flaring activity.

50 ed dexamethasone for the prophylaxis of pain flare after radiotherapy, patients were accrued from 23

51 ur of the 6 patients (66.7%) who experienced flare after switching to infliximab-abda did so within 9

52 as associated with increased risk of disease flare after treatment cessation.

53 We hypothesise that the delayed onset of RA flares after specific antibiotics is mediated through th

54 Patients who do have flares after switching may achieve quiescence with incre

55 These markers were predictors of severe ALT flares, after treatment withdrawal, and HBV DNA reactiva

56 re predictors of severe alanine transaminase flares, after treatment withdrawal, and HBV-DNA reactiva

57 d in prophylaxis and treatment of acute gout flare, alleviates the painful inflammatory response to M

58 In adult mice, FLARE also gave light- and motor-activity-dependent tran

59 nd manipulation of these neurons, we present FLARE, an engineered transcription factor that drives ex

60 tions between the values of anterior chamber flare and absolute CT changes in both temporal and infer

61 c range and robustness than first-generation FLARE and can be used in culture as well as in vivo to r

62 ure anterior chamber (AC) inflammation (both flare and cells) objectively.

63 ment HBV DNA level of 300 IU/mL predicts HBV flare and HBsAg seroclearance after anti-HCV therapy.

64 ponse further enhanced the prediction of HBV flare and HBsAg seroclearance.

65 components, threshold tracking and histamine flare and itch response and neuropathological examinatio

66 ilateral uveitis, low visual acuity, high AC flare and LF grades, and presence of posterior synechiae

67 related deaths occurred, one owing to tumour flare and one from acute myeloid leukaemia after study d

68 e activated by B cells in the weeks before a flare and subsequently migrate out of the blood into the

69 ells in the blood during the period before a flare and suggested a model in which these cells become

70 The final normalized dosage for patients who flared and remained on infliximab-abda (1.301 mg/kg/week

71 billion cubic meters (BCM) of natural gas is flared and vented in the world annually, emitting greenh

72 sociated with magnetic reconnection in solar flares and are typically enriched in electrons, helium-3

73 ts that were differentially expressed before flares and compared these with data from synovial single

74 t but long-term treatment to prevent disease flares and disease progression with intestinal complicat

75 ew emission measurements from associated gas flares and limited black carbon (BC) emission factors ha

76 ed by a higher prevalence of symptoms out of flares and oral aphthosis (both p = 0.02 compared with P

77 but durable, efficacy in decreasing disease flares and organ damage.

78 challenged by the presence of spots, plage, flares and other manifestations of magnetic 'activity' o

79 ic inflammatory skin disease with periods of flares and remission.

80 aims to dissolve MSU crystals, suppress gout flares and resolve tophi.

81 ments of fireballs reveal strong millisecond flares and significant brightness oscillations at freque

82 Flaring and fetal growth outcomes were not significantly

83 directly reported emissions from venting and flaring and four times greater than our region-specific

84 ries that utilized current industry-reported flaring and venting volumes (reported data) and quantita

85 n relative to SL, AS OCT tube parameters, AC flare, and clinical factors including IOP.

86 aring ARs, producing at least one M-/X-class flare, and nonflaring ARs.

87 overning media clarity, such as AC cells, AC flare, and phakic status (R(2)-adjusted = 0.424, P < .00

88 brosis (APRI > 1.5 or FIB-4 > 3.25), hepatic flare, and resolution of elevated APRI and FIB-4 scores.

89 tedly at five gathering facilities and three flares, and emitting equipment source-types were identif

90 r reflected in more severe itching, frequent flares, and increased disease severity in patients harbo

91 After baseline, 42.3% of eyes experienced flares, and the average number of flares reduced from 1.

92 ) and increased work of breathing (grunting, flaring, and retractions; positive LR, 2.1 [95% CI, 1.6-

93 uld be evaluated separately and that symptom flares are common and can differ considerably in intensi

94 Solar flares are powered by a rapid release of energy in the s

95 The fine structures (below 500 km) of flares are rarely observed and are accessible to only a

96 The molecular events leading to flares are unknown.

97 events like coronal mass ejections and solar flares, are organized into quasi-periodic "seasons", whi

98 350 or more identified patients with future flare (area under the curve [AUC] 0.79, 95% CI 0.66-0.88

99 ts showed decreasing (18)F-FET uptake in the flare areas in 4 patients and progress in 1 patient.

100 ween vector-magnetic-field observations from flaring ARs, producing at least one M-/X-class flare, an

101 >/=1 log10 IU/mL over baseline and hepatitis flare as an increase in alanine aminotransferase to >/=3

102 It was considered implausible that solar flares, as resulted from magnetic reconnection in the te

103 A hepatitis flare associated with increase in bilirubin or INR shoul

104 bserved in cells isolated from patients with flares associated with a streptococcal tonsillitis and w

105 s associated with a 70% increased risk of RA flare at 1-3 months, which decreases but remains signifi

106 was associated with an increased risk of RA flare at 29-90 days (IRR 1.71, CI 1.12-2.59, p = 0.012);

107 ts established a strong relationship between flared biogas ammonia (NH(3)) content and emitted nitrog

108 ity by moni-toring the dynamics of the Cdc42 FLARE biosensor using the phasor approach to FLIM-FRET.

109 Solar flares-bursts of high-energy radiation responsible for s

110 ts closely matching those observed in a C1.5 flare by the Swedish Solar Telescope.

111 Including emission control in the form of a flare can decrease the average lifecycle methane emissio

112 Flares can operate continuously for months and release h

113 Incomplete combustion during flaring can lead to production of black carbon (BC) and

114 three gas treatment cases (passive venting, flare, CH(4) conversion to electricity) and four decay r

115 The ARI index increased among all flare clinical grades (P < 0.005).

116 We conclude that Rho flares constitute a damage control mechanism that reinst

117 This suggests incomplete combustion from flares contributes almost 1/5 of the total field emissio

118 The main study outcome was frequency of flares, defined as new or worsening inflammatory activit

119 We found that Hispanics were exposed to more flares despite being less likely than non-Hispanic White

120 Flare detection sensitivity and specificity were compare

121 ry CD163 increased from 6 months preflare to flare, diminishing progressively in complete and partial

122 genes and B cell signature were decreased at flare disease state.

123 methods used to predict the occurrence of a flare during the 24-month follow-up period.

124 uly 3, 2013, and Feb 1, 2015, 17 (28%) had a flare during the 24-month follow-up.

125 anti-inflammatory therapies can reduce gout flares during initiation of urate-lowering therapy.

126 th FLG mutations had an increased risk of AD flares during pregnancy (OR 10.5, 95% CI 3.6-30.5) and o

127 sessment of skin barrier function at disease flare, during antimicrobial therapy, and post-therapy.

128 ity of a repeat EEN course to treat a future flare (EEN repeat); their opinion on how difficult EEN w

129 However, few studies have measured flare efficiency in a real-world setting.

130 nd did not have high-risk lesions for tumour flare (eg, >5 sites of visceral disease or bone lesions

131 Systemic lupus erythematosus (SLE) flares elicit progressive organ damage, leading to disab

132 in throughout the expedition showed that gas-flaring emissions from the Yamal-Khanty-Mansiysk and Nen

133 ssions during one notable approximately 24-h flaring event (during which the plume transmissivity dro

134 Exposure to a high number of nightly flare events was associated with a 50% higher odds of pr

135 were no differences in the incidence rate of flare events with the switch (IRR: 1.04; 95% CI: 0.36-2.

136 ations were exposed to twice as many nightly flare events within 5 km as those with <20% Hispanics.

137 low (1-9) or high ( >= 10) number of nightly flare events, as compared with no exposure, while contro

138 ea-for days, before and after M- and X-class flare events; (ii) systematic preflare buildup of free e

139 ave also been suggested as an explanation of flaring events and can also explain specific properties

140 lls in the blood of patients are both signal flares for the existence of a tumor and harbingers of me

141 art, to the deployment/secretion of a "decoy flare," for example, anomalous cancer-associated antigen

142 de insights into flare physics and improving flare forecasting.

143 Our study suggests exposure to flaring from OGD is associated with an increased risk of

144 nvestigated whether residential proximity to flaring from OGD was associated with shorter gestation a

145 Parallel on-site measurements of flare gas flow rate and composition were successfully pe

146 ds were shown to be strongly correlated with flare gas heating value.

147 field measurements of BC emission rates and flare gas volume-specific BC yields for a diverse range

148 Flare gas volume-specific BC yields were shown to be str

149 mation with reported estimates of vented and flared gas from the Railroad Commission of Texas enabled

150 ad Commission of Texas enabled estimation of flared gas volume at each flare.

151 of recent studies investigating transport of flare-generated BC in the Arctic and globally, impacts o

152 crudes refined in the United States because flaring GHG emissions are largely offset at the refinery

153 In cultured rat neurons, FLARE gives a light-to-dark signal ratio of 120 and a hi

154 tion evaluation including: clinical cell and flare grading and laser flare photometry (LFP).

155 compared to the late flare group, the early flare group had differential gene expression in monocyte

156 At baseline, compared to the late flare group, the early flare group had differential gene

157 , 43.1; P = .004), anterior chamber cells or flare >/= 3+ (aHR, 25.6, P < .001), posterior synechiae

158 at different times corresponding to peaks of flare hard X-ray emission.

159 e IL-1beta release in initiation of the gout flare has led to the development of anti-IL-1beta biolog

160 consider skewed distributions when assessing flare impacts globally.

161 hen incorporated into the calcium integrator FLARE, improved the signal/background ratio by 27-fold,

162 Symptom flare in IBD is associated with increased activation of

163 mmunologic factors associated with impending flare in the Biomarkers of Lupus Disease study.

164 be a noninvasive method for diagnosing renal flare in the setting of a known diagnosis of SVV.

165 were the most accurate biomarkers for early flare in this study.

166 ALT concentrations in two patients, hepatic flare in two patients, and increased lipase in one patie

167 The observation reveals the process of the flare in unprecedented detail, including the flare ribbo

168 About 7 BCM per year is flared in the United States, and half is from North Dako

169 e CD163 measurements during the treatment of flares in a subset of patients from the Mexican and long

170 of circulating PRIME cells decreased during flares in all 4 patients, and flow cytometry and sorted-

171 We measured urine CD163 at lupus nephritis flares in patients from a Mexican cohort and cross-secti

172 umab significantly reduced the occurrence of flares in patients with HES, with no new safety signals

173 e (and timing of use), and the occurrence of flares in patients with RA.

174 Patients who experience flares in the ALT level are also more likely to progress

175 irborne data of plume samples from 37 unique flares in the Bakken region of North Dakota in May 2014

176 Hispanics are disproportionately exposed to flares in the Eagle Ford shale, a pattern known as envir

177 We identified 43887 distinct oil and gas flares in the study region from 2012 to 2016, with a pea

178 ient, as well as from 235 time points during flares in three additional patients.

179 ellite product to characterize the extent of flaring in the Eagle Ford Shale region of south Texas, o

180 ed BC in the Arctic and globally, impacts of flaring in the energy industry may in fact be underestim

181 Black carbon (BC) emissions from gas flaring in the oil and gas industry are postulated to ha

182 magnetic energy is enough to power the solar flare, including the associated eruption, particle accel

183 nizing individual patients during AE disease flares is poorly understood.

184 Flaring is associated primarily with unconventional oil

185 visual acuity (OR 5.1, P = .001), high laser-flare (LF) values (OR 1.74, P = .01), and presence of po

186 ensing plasma) streaming down along the post-flare loops, and the chromosphere's response to the impa

187 with the rapid ribbon separation during the flare main phase.

188 ression permitted functional manipulation of FLARE-marked neurons.

189 These results suggest that SLE flares may arise from an overlapping spectrum of lymphoi

190 Our results suggest flaring may be a significant environmental exposure in p

191 crotubule assembly, providing a role for the flared morphology of growing microtubule ends.

192 ients (systemic reactivation n = 11, partial flare n = 3, isolated central nervous system reactivatio

193 Flares need to be accurately identified and managed.

194 Flare occurred early (within 60 days of baseline) in 21

195 ne faecal calprotectin for the prediction of flare occurring within 2 years was 0.62 (0.49-0.74; p=0.

196 UC of 0.81 (0.76-0.85) for the prediction of flare occurring within 3 months.

197 crobiome and intensified medication due to a flare of the disease.

198 The prognosis in severe acute flares of chronic hepatitis B (AFOCHB) is often unclear.

199 FN-I signature and could contribute to acute flares of disease in susceptible subjects such as patien

200 cutaneous disease and precipitates systemic flares of disease.

201 Disease flares of established atopic dermatitis (AD) are general

202 tory bowel disease (IBD) is characterized by flares of inflammation with a periodic need for increase

203 rheumatism is characterized by intermittent flares of pain, erythema and swelling in and around the

204 or soft gamma repeaters that have repetitive flares of similar luminosities.

205 h as alpha4beta7 in IBD can lead to onset or flares of SpA.

206 tinuation of low-dose naltrexone resulted in flaring of symptoms, which cleared within 2 to 3 days on

207 dizing cells, whereas cells in the oxic zone flare off electrons through intense cathodic oxygen resp

208 Solar flares often involve the acceleration of particles to re

209 sating with a period of 2.3 s during a solar flare on 2014-April-18.

210 nator infliximab went on to develop a single flare on infliximab-abda.

211 The observations of solar flare onsets show rapid increase of hard and soft X-rays

212 utilization of natural gas that is currently flared or stranded, has not yet been reported.

213 ew scalable approach that helps mitigate the flaring or direct emission of natural gas at remote loca

214 RA features sporadic 'flares' or inflammatory episodes-mostly occurring outsid

215 Some patients have recurrence of flares, or become antibiotic-dependent, and require repe

216 Flaring, or the combustion of petroleum products into th

217 y DBS sampling and CRP test regime to detect flare outside the clinic was also assessed.

218 4.5 billion cubic meters of total gas volume flared over the study period.

219 e obtained from 364 time points during eight flares over a period of 4 years in our index patient, as

220 score using naive T-cells predicted disease flare (p < 0.0001).

221 orest models showed three subgroups of early flare patients, distinguished by greater baseline freque

222 Patients experienced more flares per person-years after switching to infliximab-ab

223 aract development were the number of uveitis flares per year (hazard ratio [HR] = 3.06 [95% confidenc

224 ver, in 23% of the patients, a postoperative flare phenomenon was observed that warrants further inve

225 In 11 patients (26%), a flare phenomenon was observed, with a considerable incre

226 g: clinical cell and flare grading and laser flare photometry (LFP).

227 e (r = -0.40; P = 0.0002), and maximum laser flare photometry value (r = -0.26; P = 0.020).

228 These results provide insights into flare physics and improving flare forecasting.

229 Biogas flaring practices at AD facilities can reduce potential

230 chine learning (ML) has been used to improve flare predictions, the potential for revealing precursor

231 barrier to a comprehensive understanding of flaring processes and accurate prediction.

232 atistical evidence for (i) ARs persisting in flare-productive states-characterized by AR area-for day

233 e primary mechanism for assembly onto single flared protofilaments.

234 to identify such lesions until confirmed as flare/pseudo-progression or true PD by either biopsy or

235 The flare reaction correlated with high PD-1 expression on S

236 This cutaneous flare reaction did not result in treatment discontinuati

237 ng); 2 other patients had a delayed wheal or flare reaction.

238 e, are widely used for the treatment of gout flare; recognition of the importance of NLRP3 inflammaso

239 xperienced flares, and the average number of flares reduced from 1.8+/-0.1 flares/year to 0.6+/-0.1 f

240 t of severe systemic capillary-leak syndrome flares requiring ICU admission.

241 We discovered that Rho flares restore barrier function by driving concentration

242 nal genomic analysis of rheumatoid arthritis flares revealed PRIME cells in the blood during the peri

243 flare in unprecedented detail, including the flare ribbon propagating across the sunspots, coronal ra

244 tion is non-uniform over the sunspot: as the flare ribbon sweeps across, its different portions accel

245 nate and expand outward from the far ends of flare ribbons.

246 only MRE global score correlated with 2-year flare risk (AUC 0.71, 0.58-0.82; p=0.024).

247 wel, faecal calprotectin predicts short-term flare risk, whereas VCE predicts both short-term and lon

248 1,192 (3.7%) of RA subjects had one or more flare/s during the study period, and were therefore incl

249 antibiotic group/s appear associated with RA flare/s risk.

250 Single-chain FLARE (scFLARE) is a single polypeptide chain that incor

251 FLARE senses the coincidence of elevated cytosolic calci

252 The previously described flaring shapes of growing microtubule tips are remarkabl

253 ral resolution, and minimal dark-state leak, FLARE should be useful for the study of activity-depende

254 y, and those with a corticosteroid-resistant flare should start anti-TNF therapy.

255 We report microwave observations of a solar flare, showing spatial and temporal changes in the coron

256 s that the growing ends of MTs separate into flared single protofilaments.

257 Fourteen patients with hepatitis flare, six of whom had reactivation, required discontinu

258 nce of itch, for wheal diameter, volume, and flare size and intensity.

259 We found two ultraluminous flaring sources in globular clusters or ultracompact dwa

260 otemporal hierarchical clustering identified flaring sources, and a regression-based approach combini

261 Quantified BC emission rates from individual flares spanned more than 4 orders of magnitude (up to 53

262 ed in subjects with AD during progression to flare state, the prognostic value of baseline microbiome

263 r second for 2 minutes, as measured within a flare subvolume of ~10(28) cubic centimeters.

264 of a heavy-tail emissions distribution from flares suggests the need to consider skewed distribution

265 o biosimilar infliximab-abda experience more flares than when previously treated with the originator

266 ery 6 months for 2 years or until a clinical flare (the primary outcome, defined as an increase in th

267 Regardless of the level of flaring, the Bakken life cycle GHG emissions are compara

268 When not flaring, the sources appear to be normal accreting neutr

269 birth outcomes, but no studies have examined flaring-the open combustion of natural gas-from OGD.

270 the area of the tube; anterior chamber (AC) flare; tube insertion entry site position relative to Sc

271 measurements of fuel-specific BC yields from flares under field conditions.

272 troviral therapy (cART) and there is viremia flare up upon therapy interruption.

273 At the time of flare up, administration of prednisolone was remarkably

274 The parent-completed Asthma Flare-up Diary for Young Children (ADYC), which was deve

275 PSA flare-up during (177)Lu-PSMA treatment is very uncommon.

276 In March, 2016, a flare-up of Ebola virus disease was reported in Guinea,

277 stionnaire Effects of a Young Child's Asthma Flare-up on the Parents (ECAP) were tested in a randomiz

278 As the same drugs elicited both flare-up reactions and real DHR, drug-induced flare-up r

279 lare-up reactions and real DHR, drug-induced flare-up reactions may be precursors of a possible secon

280 endpoints were PSA changes at 12 wk and PSA flare-up.

281 not receive antiviral treatment had colitis flare-ups after the index admission.

282 EMF includes an active phase with recurrent flare-ups of inflammation evolving to a chronic phase le

283 estimated ethnic disparities in exposure to flaring using satellite observations from the Visible In

284 Median time to first flare was 5.4 years (95% confidence interval [CI], 2.2-5

285 the curve (AUC) CRP data (72.7%) to identify flares, was greater than 'minimal' AUC CRP data (54.5%).

286 dentify novel biomarkers of renal vasculitis flare, we analysed the longitudinal urinary metabolomic

287 h well permit data indicated the majority of flares were associated with oil-producing (82%) and hori

288 Phylogenetic analysis showed that disease flares were associated with the clonal expansion of the

289 Most flares were detected in the vicinity of the Hornsund Fra

290 atient demographics, including self-reported flares were recorded.

291 respiratory symptoms [apnea, stridor, nasal flaring, wheezing, chest indrawing, and/or central cyano

292 Women who have a mild to moderate disease flare while on optimized 5-ASA or thiopurine therapy sho

293 Only 1 patient had flares while on originator infliximab went on to develop

294 9 (10.1%) patients developed concomitant ALT flare with oral HBV antiviral therapy; the risk was 1.7

295 roportion of patients experiencing 1 or more flares/withdrawing from the study was 50% lower with mep

296 d case series (SCCS) of patients who have RA flares within a newly diagnosed RA cohort (n = 31,992) f

297 as the proportion of patients with 1 or more flares (worsening of HES-related symptoms necessitating

298 1-PDGFRA-negative HES, experienced 2 or more flares (worsening of HES-related symptoms or blood eosin

299 uced from 1.8+/-0.1 flares/year to 0.6+/-0.1 flares/year (P < 0.0001).

300 rage number of flares reduced from 1.8+/-0.1 flares/year to 0.6+/-0.1 flares/year (P < 0.0001).